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Abstract
Aminoglycosides (AG) are commonly prescribed antibiotics with potent bactericidal activities. One main side effect is
permanent sensorineural hearing loss, induced by selective inner ear sensory hair cell death. Much work has focused on
AG’s initiating cell death processes, however, fewer studies exist defining mechanisms of AG uptake by hair cells. The
current study investigated two proposed mechanisms of AG transport in mammalian hair cells: mechanotransducer (MET)
channels and endocytosis. To study these two mechanisms, rat cochlear explants were cultured as whole organs in
gentamicin-containing media. Two-photon imaging of Texas Red conjugated gentamicin (GTTR) uptake into live hair cells
was rapid and selective. Hypocalcemia, which increases the open probability of MET channels, increased AG entry into
hair cells. Three blockers of MET channels (curare, quinine, and amiloride) significantly reduced GTTR uptake, whereas the
endocytosis inhibitor concanavalin A did not. Dynosore quenched the fluorescence of GTTR and could not be tested.
Pharmacologic blockade of MET channels with curare or quinine, but not concanavalin A or dynosore, prevented hair cell
loss when challenged with gentamicin for up to 96 hours. Taken together, data indicate that the patency of MET
channels mediated AG entry into hair cells and its toxicity. Results suggest that limiting permeation of AGs through MET
channel or preventing their entry into endolymph are potential therapeutic targets for preventing hair cell death and
hearing loss.
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Introduction
Inner ear hair cells are the mechanosensory cells essential for
hearing function. As mammalian hair cells do not regenerate,
damage or loss of hair cells leads to permanent hearing impair-
ment. One common cause of hair cell death is exposure to
aminoglycoside antibiotics [1,2]. As a result, up to 25% of patients
treated with aminoglycosides develop irreversible sensorineural
hearing loss [3,4]. Patients suffering from recurrent or severe
infection, such as those with cystic fibrosis, are at particular high
risk of such iatrogenic hearing loss [5,6]. Entry of aminoglycosides
into hair cells is necessary to induce cell death [7]. Hair cell death
is thought to be mediated by reactive oxygen species [8,9] and
caspase activation [1,2,10,11], although caspase-independent cell
death can also occur [12]. Extensive work has characterized the
intracellular events occurring after aminoglycosides enter hair cells
[3,8,13], yet studies examining the mechanism of aminoglycoside
entry into hair cells are limited.
In hair cells, aminoglycosides block mechanotransducer (MET)
channels [14,15,16,17], ATP receptors [18], Ca-activated K
+
channels [19], and nicotinic acetylcholine receptors [20]. The
pore size of the narrowest portion of MET channels was
estimated at 1.25 nm [21], thus large enough to accommodate
the passage of dihydrostreptomycin, an aminoglycoside, whose
end-on diameter was estimated at 0.8 nm [22]. Electrophysio-
logical data on mouse cochlear hair cells suggested that dihy-
drostreptomycin (DHS) was a permeant blocker of the MET
channels in vitro [22]. Hypocalcemic conditions, which increase
the open probability of MET channels, amplified the blocking
efficacy of DHS [17] and increased neomycin’s and gentamicin’s
toxicity in hair cells [23]. In the presence of FM1-43, a per-
meant blocker of the MET channels, toxicity caused by
neomycin, a closely-related aminoglycoside, on mouse hair cells
was reduced, suggesting the two drugs compete for entry into hair
cells [24,25].
Alternatively, AGs uptake into hair cells may be via receptor-
mediated endocytosis. Endocytic pathways are present in the
apical [26,27,28] and basolateral membranes of hair cells [29]
and could provide a means of AG accumulation. The current
study demonstrates that aminoglycoside entry via MET chan-
nels is primarily responsible for uptake leading to hair cell
death.
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22347Results
Hair cell toxicity caused by aminoglycosides
The first step in assessing AG toxicity and entry mechanisms
into sensory hair cells was to develop an in vitro preparation where
toxicity could be reproducibly assessed, keeping in mind the
limited time course that was available for imaging entry. To this
end, an in-depth characterization of hair cell damage as a result of
gentamicin treatment was performed. Sensory hair cells along the
cochlea were analyzed based on tonotopic location as apical,
middle, and basal (Figure 1A). Currents of the MET channels
are present in the basal turn of the cochlea at birth and this
maturation process continues in culture conditions [30]. By iso-
lating and culturing cochleae from postnatal 4-day-old (P4) pups in
control media overnight, we investigated functional 5-day-old hair
cells, which have MET channel conductance expressed in a
tonotopic manner for outer hair cells, decreasing in a basal-apical
gradient. This model system was used to directly investigate the
role of mechanotransduction channels in aminoglycoside-induced
hair cell death (Figure 1B). AG toxicity is dependent on exposure
time, dosage and recovery time. We explored each of these in turn,
first treating for 24 hrs and then allowing 0, 24 or 48 hrs of
recovery for five doses of gentamicin (Figure 1C). Gentamicin was
chosen because of the availability of the fluorescent conjugated
compound gentamicin Texas Red (GTTR). The first experiment
exposed cultures to doses from 0.1 to 1.0 mM gentamicin for
24 hrs and then allowed recovery for 0, 24 and 48 hrs (Figure 1C).
The apical tissue was the least sensitive and basal cells most
sensitive to treatment. Disappearance of both parvalbumin 3-
labeled cell body and phalloidin-labeled stereocilia bundle of hair
cells was used for quantifying hair cell loss. Given that the hair cell
body can remain despite stereocilia bundle loss after gentamicin
treatment [31], quantification of hair cell body number was
used for the remaining experiments. Although there was little
immediate cell loss following treatment by 24 hrs, basal cell loss
was almost complete at 24 hr recovery while middle regions
showed maximal loss for doses greater than 0.1 mM. Apical pre-
parations showed loss of more than 60% only at the highest dose.
At 48 hrs of recovery all regions and all doses showed maximal
loss. This data indicates that 24 hrs of treatment is too damaging
at any dose tested. We then varied the treatment time while
maintaining a 48 hr recovery period. The results for the 0.25 mM
gentamicin dose is presented in Figure 1D where treatment times
varied from 1–24 hrs. From this data we selected the 1 hr treat-
ment time and 48 hr recovery. This treatment gives a tonotopic
loss with the base being the most severe (Figure 1D–F). Further-
more the 1 hr treatment can be used for time lapse imaging of
uptake properties as well.
Figure 1. Gentamicin causes outer hair cell loss. A. Low magnification view of an isolated organ of Corti from a postnatal 4-day-old (P4) rat. B.
Schematic of two proposed mechanisms of aminoglycoside (red dots) entry into hair cells via mechanotransducer channels (green) on stereociliary
bundle or endocytosis (on apical or basolateral membranes). C. P4 cochleae were cultured overnight before treatment with gentamicin (0, 0.1, 0.25,
0.5, and 1.0 mM) for 24 hr, followed by 0-, 24-, or 48-hr recovery periods. Counts of phalloidin- and parvalbumin-labeled hair cells revealed that no
significant hair cell loss at the end of a 24-hr treatment. With additional recovery periods, the middle and basal turns were most susceptible to hair
cell loss. D. Cochleae were treated with 0.25 mM gentamicin for 1–24 hours followed by a 48-hr, antibiotic-free recovery. After 1-hr treatment, an
apical-basal gradient of hair cell loss was observed. Arrow indicates the treatment paradigm chosen for the Panels E–F. Each data point represents an
analysis of three to ten experiments. E–F. Representative images of control cochleae and those treated with gentamicin (0.25 mM) for 1 hr, followed
by a 48-hr recovery period. Damage to parvalbumin 3-labeled hair cells was noted in the middle and basal turns of the cochlea (notably in OHCs rows
1 and 2). Error bars=S.D. Scale bars=250 mmi nA ,2 0mm in C–D.
doi:10.1371/journal.pone.0022347.g001
Aminoglycoside Entry into Hair Cells
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22347Gentamicin uptake into hair cells
The Texas Red-conjugated version of gentamicin (GTTR)
allows for live imaging of drug uptake in hair cells [32]. To
determine the toxicity profile of GTTR in our in vitro prepara-
tion of rat cochlea, the dose-response relationship between
outer hair cell survival and GTTR concentration was investigat-
ed. Like gentamicin, a dose-dependent outer hair cell loss was
noted for GTTR, with the basal turn being the most susceptible
(Figure 2A–B). Imaging for NADH signals found that both
hair cells and support cells are robust prior to GTTR ad-
ministration (Figure 2E). In the time frame recorded, uptake
of GTTR was detected preferentially in outer and inner hair
cells and not in adjacent prox1-labeled supporting cells (Figure
2C). Similar localization was observed for GTTR as for myo-
sin 7a, again supporting selective hair cell uptake. Comparison
of GTTR label with staining obtained using a specific anti-
body for gentamicin (Figure 2F–G) also demonstrates strong
colocalization.
Figure 2. Gentamicin selectively enters hair cells. A–B. The dose-response relationship between GTTR and outer hair cell survival was
determined.CochleaeweretreatedwithGTTRfor1 hrandallowedtorecoverfor48 hrindrugfreemedia.Likenative(orunconjugated)gentamicin,the
basal and middle turns were more susceptible to hair cells loss when treated with GTTR. C–D. GTTR (3 mM) selectively entered inner and outer hair cells
and not adjacent prox1-labeled supporting cells (Deiters’ and pillar cells). Staining for myosin 7a, a specific marker for outer and inner hair cells,i naP 3
mouse cochlea exhibited a similar expression pattern as GTTR. E. NADH signals were detected in both outer and inner hair cells in cochlear organs
deemed healthy for analysis for GTTR uptake. F–G. Cochleae cultured in the presence of gentamicin (0.1 mM for 1 hr followed by a 48 hr drug free
recovery period) were immunolabeled for gentamicin, which was detected only in myosin 7a-positive hair cells. Error bars=S.D. Scale bars=20 mm.
doi:10.1371/journal.pone.0022347.g002
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pathway, organ of Corti cultures were incubated at 37uC with
GTTR for 1 hr in the absence and presence of the open channel
blocker curare (Figure 3). Figure 3A shows the apical and middle
turns where IHC and OHCs were selectively labelled. Some
labelling also appears in the remaining portions of Reissner’s
membrane. Curare, significantly reduces the labelling in hair cells.
Figure 3C–D summarizes the uptake as measured in OHCs (C)
and IHCs (D). Curare significantly reduced uptake in both cell
types. We next further investigated the time course of GTTR
uptake under two-photon microscopy.
Two-photon imaging was used to monitor uptake of GTTR into
cultured organ of Corti. The thin focal planes obtained with
two-photon microscopy allowed for imaging in the presence of
GTTR-containing media, while also limiting photobleaching and
phototoxicity. Prior to GTTR application, endogenous fluorescent
emission of NADH was observed as an indication of tissue viability
(Figure 2E). A lack of NADH signal was interpreted as poor tissue
viability and those organs were discarded prior to experimenta-
tion. At a normal extracellular calcium concentration (1.2 mM),
GTTR was rapidly taken up into the outer hair cells (t=21.0
60.2 min; Figure 4A). A time lapse video of uptake can be found
in Movie S1. This movie illustrates the selectivity of GTTR for
hair cells. When applied alone, Texas Red was not detected in
either hair cells or supporting cells in the organ of Corti (Figures 4C
and H). GTTR (3 mM) demonstrated a steep rate of uptake in the
first 30 minutes (Figures 4G–H). Hypocalcemic conditions, which
increased the open probability of MET channels [33,34], raised
the rate of GTTR uptake (t=13.560.2 min; Figures 4D and G).
Increasing the concentration of GTTR (to 30 mM) also sharply
elevated its rate of uptake into hair cells (t=9.060.5 min;
Figures 4B and H). No significant GTTR uptake was detected
in surrounding supporting cells when GTTR (3 mM) was applied
in media containing 1.2 mM [Ca
2+] (Figure 4A). Lowering extra-
cellular [Ca
2+] or raising GTTR concentration did not increase
GTTR uptake into supporting cells, suggesting that they are not
equipped with the mechanisms needed for rapid GTTR uptake
present in inner and outer hair cells. GTTR was observed outside
hair cells in a delayed fashion (.10 min) both under hypocalcemia
(arrowheads in Figure 4B) and high dose GTTR (30 mM)
treatment (arrowheads in Figure 4D). This observation is possibly
related to leakage of GTTR into the intercellular space as result of
damage to the hair cells. Otherwise, the lack of GTTR between
cells (particularly OHCs) suggests tight compartmentalization and
limited diffusion. Punctate labelling near the basolateral aspects of
inner hair cells was occasionally observed when GTTR was
administered and was not affected by co-treatment with blockers
of MET channels or endocytosis. One possible explanation for
these punctate labelling is direct uptake into nerve terminals
immediately adjacent to inner hair cells, as gentamicin has been
Figure 3. Open MET channels are required for GTTR entry into hair cells. A. Following incubation in control media for 24 hr, P3 rat cochleae
treated with GTTR alone (3 mM for 1 hr at 37uC) showed robust uptake in inner (asterisk) and outer hair cells (OHC) in the middle and basal cochlear
turns. B. Co-treatment with curare (1 mM) effectively prevented GTTR uptake. C–D. Quantification of GTTR fluorescent intensity demonstrated that
uptake is significantly reduced by blocking MET channels with curare in both the inner and outer hair cells throughout the cochlear turns. Error
bars=S.D. Scale bars=100 mm.
doi:10.1371/journal.pone.0022347.g003
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uptake remains to be explored.
In many cells, the amphipathic styryl dye FM1-43 is inter-
nalized via endocytosis [36]. However, its rapid entry into hair
cells depends upon open MET channels [24,25], thus making it a
useful compound to compare kinetics with GTTR. When applied
at 0.75 mM, its entry into hair cells was rapidly detected in outer
hair cells (t=12.060.5 min; Figures 4E and H). Its rate of entry
Figure 4. Two-photon imaging for GTTR uptake in live cochlear hair cells. P3 cochleae were cultured for 24 hr before being treated with
GTTR or FM1-43 for an hour at room temperature. A–H. GTTR (3 mM) rapidly entered hair cells, whereas Texas Red alone (3 mM) did not. Both high
dose GTTR (30 mM) and hypocalcemic conditions promoted GTTR entry into hair cells. In these 2 conditions GTTR was rarely observed outside hair
cells in a delayed (.10 min) fashion (arrowheads). E–F. The amphiphatic dye FM1-43 has been shown to be a permeant blocker of the MET channel.
The entry of FM1-43 (0.75 mM) (E–F in pink background) into hair cells was more rapid (note different time scale) than GTTR (A–D in yellow
background) and was also promoted by increasing its concentration (7.5 mM). Error bars=S.D. Scale bar=20 mm.
doi:10.1371/journal.pone.0022347.g004
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(t=2.460.2 min; Figures 4F and H). The difference in entry rates
between FM1-43 and GTTR is likely related to the higher affinity
of FM1-43 for the MET channel [17,25].
To assess the effects of MET channel conductance and
endocytosis on the rate of GTTR uptake into hair cells, MET
channel blockers representing different chemical classes were used:
curare, quinine, and amiloride. GTTR alone entered outer hair
cells at a rapid rate (t=2461 min), plateauing during the
60 minutes of treatment. For the following experiments, the
intensity of fluorescence at 60 minutes (F60) was normalized to this
value. Co-treatment with MET channel blockers effectively slowed
and reduced uptake of GTTR into hair cells (Figures 5B–C, F).
At the concentrations tested, quinine (t=246.064.0 min, 2467
normalized F60) and curare (t=83.065.0 min, 7064 normalized
F60) were both effective in blocking GTTR uptake. When
amiloride was simultaneously applied, an initial phase of GTTR
uptake as rapid as that of GTTR alone was observed, followed by
a second phase of slower uptake (t1=2161.0 min and t2=135.06
7.0 min, 6565 normalized F60). That GTTR uptake was not
completely antagonized is a function of the competitive nature of
the block and does not provide evidence for an alternate uptake
mechanism.
To more directly test endocytosis as an alternative pathway,
concanavalin A and dynosore were tested as nonselective blockers
of endocytosis. The rate and final amount of GTTR uptake in
outer hair cells were not significantly altered by the co-application
of concanavalin A (Figure 5; t=2461.0 min; 9267 normalized
F60). The effect of dynosore treatment on GTTR uptake could not
be determined because it effectively quenched the fluorescence of
GTTR upon application (see Figure S1). Taken together, GTTR
entry into hair cells was highly dependent on the patency of MET
channels.
To determine the role of mechanotransduction in aminoglyco-
side-induced hair cell toxicity, the same MET channel blockers
were used to limit aminoglycoside toxicity in the following
experiments. Cochlear cultures were co-treated with gentamicin
and the following MET blockers: quinine, curare, AM1-43, and
amiloride. The experimental design was to treat with aminogly-
coside alone, antagonist alone, or to co-treat with both
compounds. Only experiments where the dose of antagonist did
not damage cochlear cultures were included. Administration of
AM1-43 (0.25–1.0 mM) proved to be toxic to the sensory
epithelium and was therefore excluded from further analysis.
When co-administered with gentamicin, both quinine and curare
conferred protection against hair cell loss (Figure 6, Figure 7). Hair
cell survival was significantly improved by quinine doses of
0.5 mM (92.6% vs. 23.5% in the basal turn; p,0.001) and
1.0 mM (99.6%; p,0.001) and by curare 1.0 mM (99.6%;
p,0.001; Figure 6, Figure 7). Although a trend towards improved
hair cell survival was observed with co-treatment with amiloride,
the degree of protection was variable and did not reach statistical
significance (60%; p=0.4; Figure 6, Figure 7).
When curare was simultaneously applied with other aminogly-
cosides, significantly improved hair cell survival was observed (see
Figure 7C). For groups treated with streptomycin (hair cell survival
improved to 98% from 35%; p,0.01) and dihydrostreptomycin
(hair cell survival improved to 102% from 42%; p,0.001). Only a
trend towards improved hair cell survival was noted in the
neomycin-treated group (hair cell survival: 78% as compared to
55%; p=0.05). These data suggest that aminoglycosides are
similarly entering hair cells via MET channels, the different
efficacy likely relates to how well curare competes with the AG or
differences in toxicities of the compounds after entry into hair cells.
By constructing molecular models of the tested aminoglycosides
(streptomycin, dihydrostreptomycin, neomycin, and gentamicin),
end-on diameters were estimated to be smaller than the proposed
MET channel pore size of 1.2560.08 nm [21]: 1.04 nm
(streptomycin and DHS), 0.98 nm (gentamicin), and 0.96 nm
(neomycin).
To determine whether endocytosis played a similar role in
aminoglycoside uptake, several inhibitors of this process were also
tested. When concanavalin A (Con A; 2.6 mM), a general inhibitor
of endocytosis, was co-administered with gentamicin, no signifi-
cant protection of hair cells was observed (basal turn: 36%; p=0.2;
Figure 6, Figure 7). Inhibition of dynamin by dynosore (80 mM)
prevents clathrin-mediated endocytosis [37]. Dynosore did not
improve hair cell survival when challenged by gentamicin
treatment (basal turn: 24% survival; p=0.3; Figure 6, Figure 7).
Phenylarsine oxide another inhibitor of endocytosis proved to be
toxic and so could not be evaluated. Taken together, blockers of
MET channels provided significant protection of gentamicin-
induced outer hair cell loss, whereas inhibition of endocytosis did
not.
To test whether MET channel blockers prevented or delayed
hair cell death, cultures were maintained for up to 96 hours post
treatment. Figure 8 illustrates these results, demonstrating that
hair cell survival was enhanced even after an extended recovery
period (100% vs. 32%; p,0.001). It should be noted that changing
the experimental paradigm could alter the efficacy of the channel
blockers. Given that the aminoglycosides are competing with the
channel blockers and the channel blockers are not irreversibly
binding to the channel, longer exposure times or higher doses of
aminoglycosides would be expected to overwhelm the blocking
agents. Competitive blocking of the channel is expected to slow,
not prevent entry; therefore, at equilibrium a similar amount of
aminoglycoside is expected to have entered the cell, what is
different is the time it takes to reach equilibrium. However, this
was not observed, as MET channel blockers did effectively prevent
hair cell death.
Discussion
A serious side-effect of aminoglycoside antibiotics is irreversible
sensorineural hearing loss, which occurs in up to 1 in 4 treated
patients [3]. By entering and damaging cochlear hair cells,
aminoglycosides cause hair cell death and consequently hearing
loss. One possible intervention is to reduce or prevent aminogly-
coside uptake into sensory hair cells. The current study was
designed to investigate the effects of perturbing two proposed
mechanisms of aminoglycoside uptake on hair cell survival.
Similar to previous results using in vitro and in vivo models
[38,39], we found basal outer hair cells to be the most susceptible
to damage from gentamicin in vitro. This susceptibility may be
explained in part by the higher open probability and single
channel conductance of MET channels in hair cells residing in this
region [40]. But lower levels of antioxidants among basal hair cells
have also been proposed to be responsible for this differential
susceptibility [38]. At the early postnatal ages tested, the open
probability of the MET channel is the highest in the basal turn,
and decreases in a basal-to-apical gradient [30]. All the
aminoglycoside antibiotics tested, including GTTR, resulted in a
similar damage profile, suggesting a common mechanism of
damage and entry into hair cells among these molecules. In
support of this notion, we observed loss of apical hair cells with
prolonged (24 hr) or high concentration (1.0 mM) of gentamicin
treatment, suggesting that increasing the driving force of
gentamicin entry into hair cells can overcome a lower open
Aminoglycoside Entry into Hair Cells
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observation is in agreement with other damage protocols that
yielded nearly complete outer hair cell loss [39,41].
GTTR uptake into hair cells was enhanced by hypocalcemic
conditions, which increases the open probability of the MET
channel [34,42]. This observation is in agreement with the
previous findings that hypocalcemia increased the toxicity of
aminoglycosides to hair cells [23]. Similarly, treatment paradigms
that decrease the open probability of the MET channel, such as
hypercalcemia and myosin 7a deficiency, conferred protection to
hair cells from aminoglycosides [23,28]. Alternatively, quinine and
curare provided hair cells with protection by blocking the MET
Figure 5. Kinetics of GTTR uptake with blockers of MET channel or endocytosis. A–G. Both curare (1 mM) and amiloride (0.3 mM) reduced
GTTR uptake into outer hair cells, but an initial rise in GTTR uptake, like that seen when cochleae were treated with GTTR alone, was still observed
despite amiloride co-treatment. Quinine (1 mM) was the most effective in limiting GTTR uptake among all the drugs tested. No significant change in
GTTR uptake was seen with concanavalin A (2.6 mM) treatment. Error bars=S.D. Scale bar=20 mm.
doi:10.1371/journal.pone.0022347.g005
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are consistent with previous findings that compounds that block
aminoglycoside uptake into hair cells are protective [43]. Unlike
curare and quinine, amiloride was not as potent at protecting hair
cells from gentamicin toxicity. Although it decreased GTTR
uptake into hair cells, an initial phase of rapid uptake, comparable
to gentamicin alone was observed followed by a slowing of entry,
leaving a final GTTR fluorescence comparable to that of curare
co-treatment. It is possible that amiloride, which actually binds to
the channel and is not an open or permeable blocker, was less
effective in limiting the rate of aminoglycoside entry, which may
be an important factor for its ultimate toxicity [44]. In light of the
extensive body of work demonstrating that aminoglycosides cause
a rapid increase in reactive oxygen species in hair cells [8], the rate
of aminoglycoside entry into hair cells may be important as the
levels of antioxidants in hair cells are limited and may be
overwhelmed analogous to any other buffering system [38].
Our results suggest that endocytosis does not play a major role
in gentamicin–induce hair cell toxicity. The pharmacology for
blocking endocytosis is limited and not very specific given the
Figure 6. Blockers of MET channels, but not endocytosis, protect hair cells from gentamicin toxicity. A–G. Cochleae were harvested
from P4 rats and cultured in antibiotic-free media for 24 hr before treated with gentamicin (0.1 mM) for 1 hr, followed by a 48-hr antibiotic-free
recovery period. Tissues were fixed and labeled with parvalbumin 3 antibody. Representative confocal images from each region of the cochlea are
shown. When applied concurrently with gentamicin, both curare (1 mM) and quinine (0.5 mM), improved hair cell survival. No significant protection
was observed with a different MET channel blocker, amiloride (300 mM), or when blockers of endocytosis (concanavalin A 2.6 mm or dynosore 80 mM)
were co-administered. Scale bar=20 mm.
doi:10.1371/journal.pone.0022347.g006
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mediates some uptake of aminoglycosides, which can be detected
in subcellar compartments such as lysosomes and endoplasmic
reticulum [27,45,46]. It is also possible that compartmentalization
occurs after entry. Another limitation of our current study is that
we cannot rule out the possibility that other transport mechanisms
might also contribute to AG uptake under other pathologic
conditions, such as those by other channels [47]. It would be
interesting to elucidate these modes of entry and role of com-
partmentalized aminoglycosides in future studies.
Although the role of endocytosis may be underestimated,
the importance of MET channels is clear. Given the striking
protection observed under conditions where the MET channels
were largely biased closed, the role of the MET channels may be
even more important than presented. Under physiological
conditions where calcium is low in the endolymph, the
probability of opening of MET channels is much larger than
tested here. Also entry of the AGs is driven electrically. Present
studies simply used existing membrane potential of the hair cells
in culture, rather than increasing driving forces presented by the
endocochlear potential and the endolymph solution, or in the
case of the GTTR experiments, the warmer temperature. Under
more physiological conditions the MET channel open probability
is predicted to be closer to 0.3–0.5 as compared to culture
condition where it is 0.05–0.1 [42] and the current amplitudes
in vivo would be predicted to increase close to an order of
magnitude, thus uptake via this mechanism is predicted to be
greatly enhanced. The one caveat to this argument is that AGs
Figure 7. Quantitative analysis of outer hair cell survival. A. Curare, quinine, amiloride, concanavalin A, and dynosore were administered
individually to rat cochlear cultures and found not to affect outer hair cell survival (determined by parvalbumin 3 labeling). B. Both curare and quinine
provided significant protection to outer hair cells from gentamicin damage in both the basal and middle turns of the cochlea. No significant
protection from gentamicin toxicity was observed when cochleae were co-treated with amiloride, concanavalin A or dynosore. C. Curare significantly
improved outer hair cell survival in the basal turn of cochleae exposed to various aminoglycosides, including streptomycin and dihydrostreptomycin,
but not neomycin. Error bars=S.D. *=p,0.001, **=p,0.01.
doi:10.1371/journal.pone.0022347.g007
Aminoglycoside Entry into Hair Cells
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MET channels.
Previous studies have demonstrated that the level of aminogly-
coside in the inner ear endolymph does not reach that of plasma,
but its clearance time is extremely slow (.30 days) [48]. As steady
state levels are a function of both entry and clearance, it is possible
that lower endolymph levels reflect high rates of entry into hair
cells reducing steady-state values. Alternatively the lower levels in
endolymph may explain the lack of immediate hearing loss due to
blockage of MET channels prior to hair cell damage. Given that
hair cells do not metabolize the AG, accumulation will be cumula-
tive so low levels in endolymph do not reduce the likelihood of
entry via MET channels. Studies that examine the kinetics of
aminoglycoside entry into the inner ear and sensory hair cells in
vivo will help shed light on these possible mechanisms.
Although the molecular composition of the MET channel
remains elusive, its pharmacologic and electrophysiologic proper-
ties have been characterized [21,22,33,34,49]. Within the inner
ear, only the sensory hair cells exhibit properties of the MET
channels. The narrowest portion of the MET channel was
estimated at 1.2560.08 nm [21], thus large enough to accommo-
date the passage of the aminoglycoside dihydrostreptomycin [22]
and the styryl dye FM1-43 [24,25]. Measurements of the end-on
diameters of streptomycin, dihydrostreptomycin, neomycin and
gentamicin also found them small enough to pass through these
channels. When applied to cochlear hair cells in vitro, both
gentamicin and GTTR (Figure 2) are selectively taken up by outer
and inner hair cells, but not in adjacent supporting cells. The end-
on diameter of GTTR was estimated to be 1.47 nm and thus
larger than the reported MET channel pore size (1.25 nm) [21].
Two possible explanations for the observed GTTR uptake into
hair cells are first that the MET channel pore size has been
underestimated, and second that the MET channel pore tem-
porarily dilates during GTTR entry. In the latter scenario, such a
dynamic and reversible dilation has been characterized in other
nonselective cation channels [50,51]. The proposed characteristics
are hypothetical and warrant further investigation.
Uptake of gentamicin via receptor-mediated endocytosis was
found to occur in proximal renal tubular cells requiring the
receptor megalin [52]. While megalin expression is found in the
Figure 8. Curare protected hair cells in long-term cultures. A–C. Cochleae treated with gentamicin (0.1 mM) with or without curare (1.0 mM)
remained in gentamicin-free media for four additional days. Survival of outer hair cells (determined by parvalbumin 3 labeling) in the curare-treated
cochleae was comparable to that in untreated, cultured cochleae. D. Quantitative analysis of the gentamicin-treated cochleae demonstrated a slight
decline in outer hair cell survival 96 hr versus 48 hr after treatment. Cochleae co-treated with curare and gentamicin have comparable numbers of
outer hair cells at both time points. Each data point represents an analysis of three to twenty-two experiments. E. Schematic of possible entry
pathways for aminoglycoside first into the scala media from the stria vasculars or Reissner’s membrane, then into sensory hair cells in the inner ear.
Error bars=S.D. Scale bar=50 mm.
doi:10.1371/journal.pone.0022347.g008
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whether it similarly binds and transports aminoglycosides in the
cochlea is not yet determined. This mechanism of transport in the
stria vascularis would be particularly interesting since this is the site
where endolymph is produced and aminoglycoside are thought to
enter the labyrinth [32]. Inhibiting entry into endolymph may
prevent entry into hair cells via MET channels (Figure 8E). Given
that MET channels are located atop the stereocilia hair bundles
bathed in the scala media, an enclosed fluid compartment with
no direct access to a blood supply, aminoglycosides must be
transported into endolymph, likely from the stria vascularis [32].
Preventing aminoglycoside entry into the endolymph compart-
ment therefore would be expected to limit toxicity. Alternatively,
modifying aminoglycosides to sterically limit their entry into MET
channels should also be expected to alleviate ototoxicity. More
studies are necessary to validate this potential benefit, including
experiments in the whole animal.
In conclusion, hair cell susceptibility to aminoglycoside anti-
biotics stems from the rapid accumulation of these compounds
into the sensory cells because of the novel access via mechan-
otransducer channels. Preventing access to these channels or per-
meation of these channels may be viable therapeutic approaches to
improving the value of aminoglycosides.
Materials and Methods
Animals and cochlear cultures
Sprague-Dawley rats and C57BL/6 mice were obtained from
Charles River laboratory (Cambridge, MA) and Jackson Labora-
tory (Bar Harbor, ME). All procedures involving animals were
approved by the Stanford University committee on animal
research (Assurance number A3213-01, Protocol ID 18606).
Tissue cultures
Cochleae were freshly isolated from rat pups. The temporal
bones with stria vascularis and modiolus were removed. Whole
mount cochleae were then placed onto 10 mm coverslips (Fisher
Scientific, Pittsburgh, PA) pre-coated with CellTaK (BD Biosci-
ences, San Jose, CA), and incubated in Dulbecco’s Modified Eagle
Medium/F12 (Invitrogen, Carlsbad, CA) supplemented with 10%
FBS and ampicillin (50 mg/ml; Sigma, St. Louis, MO) for 1–5 days
at 37uC in a 5% CO2 atmosphere. Culture media was replenished
every 1–2 days. The following drugs were tested: gentamicin,
streptomycin, dihydrostreptomycin, neomycin, quinine, amiloride,
concanavalin A, dynasore, phenylarsine oxide (all from Sigma),
curare (Fisher Scientific), AM1-43 and FM1-43 (Invitrogen).
Functional postnatal-day-5 cochleae were specifically chosen for
our experiments because most apical and basal hair cells carry
transduction currents at this age [30].
Immunohistochemistry and image analyses
Cochlear organs were fixed in 4% PFA for 30 minutes at room
temperature (RT), and then immersed in blocking solution [5%
goat or donkey serum, 0.1% triton X-100, 1% bovine serum
albumin (BSA), and 0.02% sodium azide (NaN3) solution in
phosphate buffered solution (PBS) for 1 hour at RT. They were
then incubated with primary antibodies in blocking solution
overnight at 4uC in a humidified chamber. The following day,
tissues were rinsed with PBS three times, and then incubated with
secondary antibodies (0.1% triton X-100, 1% BSA, and 0.02%
NaN3 solution in PBS) for 1 hour at RT. For labelling for
filamentous actin, fluorescently-conjugated phalloidin (Sigma)
was applied in 0.1% triton X-100 in PBS for 1 hour. After
washing with PBS, tissues were mounted in antifade Fluorescence
Mounting Medium (DAKO, Carpinteria, CA) and coverslipped.
The following antibodies were used: anti-myosin 7a (1:1000;
Proteus Bioscience, Ramona, CA) [39]; anti-Prox1 (1:1000; Mil-
lipore, Billerica, MA) [54]; anti-parvalbumin 3 (1:1000) [55]; anti-
gentamicin (1:200; QED Bioscience, San Diego, CA) [56]. The
specificity of these antibodies has been previously determined in
the referenced studies and/or by their respective suppliers. The
respective secondary antibodies were conjugated to either FITC,
TRITC or Cy5 (1:200; Jackson ImmunoResearch, West Grove,
PA). Images were acquired using epifluorescent or confocal micro-
scopy (Axioplan 2, Zeiss, Germany) and analyzed with Photoshop
CS4 (Adobe Systems, San Jose, CA). The cochlea was divided into
apical, middle and basal turns, and separately analyzed. At least 2
representative areas were sampled from each turn for cell
quantification. Student t-test was used for statistical comparison.
Three-dimensional reconstruction of z-stack images was processed
using the Volocity software (v5.3.0; Improvision, Waltham, MA).
Two-photon live imaging
Cochlear organs were cultured overnight as described above,
then washed with L-15 (Sigma) before imaging. Gentamicin sulfate
(Sigma) and succinimidyl esters of Texas Red dye (Invitrogen)
were conjugated to compose GTTR, which was purified before
use [32]. GTTR (3–30 mM) and FM1-43 (0.75–7.5 mM) were
directly added to cochlear cultures. In experiments testing blockers
of MET channels or endocytosis, compounds were concurrently
added with GTTR. An Olympus BX-61 (Olympus, Center Valley,
PA) coupled to the Prairie Ultima two photon laser scanning
microscope with a 1006, 0.9 numerical aperture water immersion
objective (Olympus LUMPlan) was used to image the middle turn
of the organ of Corti. A 520 nm long-pass dichroic filter (Chroma
Technology, Bellows Falls, VT) was used to separate the fluo-
rescence emission into two channels and detected by photo-
multiplier tubes. Using Prairieview software at 1.46magnification
(Prairie Technologies, Middleton, WI), 60-minute time series were
collected at 1-minute intervals. Femtosecond pulses of 900 nm
illumination from a tunable Chameleon XR laser (Coherent,
Santa Clara, CA) were scanned across the sample using galvano-
meters, power was regulated with a pockel cell. Red fluorescence
originating from GTTR was isolated using a bandpass filter (620/
60, Chroma Technology). Prior to adding GTTR, samples were
scanned at 740 nm and blue NADH intrinsic fluorescence
detected with a bandpass filter (480/30) to confirm the viability
of the sample [57] (see Figure 2E). Samples with low NADH
signals were discarded.
Data Analysis
To quantify the fluorescence intensity, at least ten individual
cells were selected as regions of interest (ROIs) in each T-series.
Using Image J software (NIH), the pixels in the ROIs were
averaged to determine the total fluorescence intensity. The
average background intensity was negligible and therefore was
not subtracted from the total fluorescence. The fluorescence for
the ten cells was averaged to create a single average fluorescence
per T-series. The average of each T-series was normalized to the
maximum fluorescence (from experiments using 3 mM GTTR in
1.2 mM calcium) and this normalized average and the standard
deviation was plotted as a function of time (OriginLab, North-
ampton, MA) to determine the average increase in cellular
fluorescence over time after GTTR administration (see Figure 4G).
In experiments measuring FM1-43 uptake, the average of each
T-series was normalized to the maximum fluorescence from
experiments using FM1-43 at 0.75 mM (see Figure 4H). Best fit
curves were produced using the formula Y=12Ae
(2x/
t
), from
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(2x/
t
) was
used for experiments examining hypocalcemic conditions and
Y=12(Ae
(2x/
t1
)+Be
(x/
t2
) for experiments examining amiloride.
Chemical models
Drugs were reconstructed using CPK precision Molecular
Models (Ealing, South Natick, MA).
Supporting Information
Figure S1 Dynosore quenches fluorescence of GTTR. A.
Co-treatment with GTTR (3 mM) and dynosore (80 mM) effectively
made GTTR undetectable. B. When GTTR was first added and
allowed to enter hair cells and dynosore was later added (15 min),
an abrupt plateau of GTTR fluorescence was observed. Error
bars=S.D.
(TIF)
Movie S1 Time lapse movie of GTTR uptake. Cochleae
harvested from P4 rats were cultured overnight before being
treated with GTTR (3 mM). Images were captured every minute
for a total of 1 hr under two-photon microscopy.
(MOV)
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